ADC Therapeutics SA Annual Net Cash Provided by (Used in) Investing Activities in USD from 2022 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Summary
ADC Therapeutics SA quarterly/annual Net Cash Provided by (Used in) Investing Activities history and growth rate from 2022 to 2023.
  • ADC Therapeutics SA Net Cash Provided by (Used in) Investing Activities for the quarter ending March 31, 2024 was -$531K, a 47.7% increase year-over-year.
  • ADC Therapeutics SA annual Net Cash Provided by (Used in) Investing Activities for 2023 was -$3.22M, a 368% decline from 2022.
Net Cash Provided by (Used in) Investing Activities, Annual (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$3.22M -$2.53M -368% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-13
2022 -$687K Jan 1, 2022 Dec 31, 2022 10-K 2024-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.